Corcept Therapeutics
CORT
#2470
Rank
A$10.58 B
Marketcap
A$96.74
Share price
-0.78%
Change (1 day)
-17.49%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): A$0.15 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.96 Billion. In 2025 the company made an earning of A$67.22 Million a decrease over its 2024 earnings that were of A$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.15 B137.93%
2025 A$67.22 M-67.29%
2024 A$0.20 B27.66%
2023 A$0.16 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.18 B-2.91%
2020 A$0.19 B14.87%
2019 A$0.16 B24.71%
2018 A$0.13 B69.32%
2017 A$79.31 M419.26%
2016 A$15.27 M-395.64%
2015 -A$5.17 Million-87.53%
2014 -A$41.45 Million-33.44%
2013 -A$62.27 Million
2011 -A$48.52 Million17.84%
2010 -A$41.18 Million35.5%
2009 -A$30.39 Million2.84%
2008 -A$29.55 Million60.81%
2007 -A$18.38 Million-52.14%
2006 -A$38.39 Million20.91%
2005 -A$31.76 Million31.87%
2004 -A$24.08 Million60.54%
2003 -A$15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.09 B 16,779.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.97 B 11,299.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.45 B 6,182.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.17 B 31,249.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.08 B 5,961.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.00 B 10,117.29%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$73.02 Million-143.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-28.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$65.52 M-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA